Pharma outfit Cipla, which he chairs in a nonexecutive capacity, recently acquired 2 American generics firms for $550 million in bid to expand in that market. In June nephew, Kamil, who was being groomed to run Cipla, resigned from the company. Niece Samina Vaziralli joined the board in July. She's overseeing a new venture to make consumer health care products, which has secured investments from Fidelity's Indian private equity arm.